ENTITY
Sun Pharmaceutical Industries

Sun Pharmaceutical Industries (SUNP IN)

143
Analysis
Health CareIndia
Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.
more
Refresh
06 Aug 2018 17:11

Para IV Winners and Losers - July 2018

This month’s Para IV developments suggest that there is likely to be benefit to Par Pharma, Dr. Reddy'S Laboratories (DRRD IN) & Amneal...

Logo
286 Views
Share
10 Jul 2018 15:02

Para IV Winners and Losers - June 2018

This month’s Para IV developments suggest that there is likely to be benefit to Baxter International Inc (BAX US) on Premix Precedex (4mc/ml), Endo...

Logo
332 Views
Share
07 Jun 2018 21:45

Para IV Winners & Losers - May 2018

This month’s Para IV developments suggest that there is likely to be benefit to Amneal Pharmaceuticals Inc (AMRX US) on Lialda, BioQ pharma for...

Logo
115 Views
Share
01 Jun 2018 17:08

Sun Pharma Specialty Research Pipeline – A Game Changer

Sun Pharmaceutical Indus (SUNP IN) currently has 2 specialty research products in the US market (Odomzo, Bromsite) and 4 approvals pending launch...

Logo
184 Views
Share
13 Apr 2018 15:14

IPCA Labs- The Revival Story

Ipca Laboratories Ltd (IPCA IN) is a fully integrated Indian pharmaceutical company. In FY17 45% of its revenues came from Indian dosage business,...

Logo
182 Views
Share
x